FEDERAL GOVERNMENT WEBSITES
JOURNALS
NEW PAPERS AND REPORTS
OTHER WEBSITES OF INTEREST
JRW Behavioral Health Services
Above and Beyond Family Recovery Center
Addiction Technology Transfer Center Network
ASAM "This week in addiction medicine"
Canadian Centre on Substance Use and Addiction
Center on Substance Abuse Research
Global Drug Survey (World's largest drug use survey)
JAMA Substance Use and Addiction Archive
NAADAC (The association for addiction professionals)
Prevention Technology Transfer Center Network
Online Museum of African American Addictions, Treatment and
The Center for Collegiate Recovery
Treatment Alternatives for Safer Communities
Changing approaches to treating opioid withdrawal in the USA (The Lancet, May 31, 2023)
Neurobiological Correlates of Psilocybin Response in Depression (Psychiatrist.com, May 30, 2023)
Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder (JAMA Psychiatry, May 30, 2023)
Trends in Illicit Ketamine Seizures in the US: 2017-2020 (JAMA Psychiatry, May 30, 2023)
Are there clinical, psychopathological and therapy outcomes correlates associated with self-exclusion from gambling? (Journal of Behavioral Addictions, May 27, 2023)
Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care (JAMA Network Open, May 27, 2023)
Self-reported adverse events associated with ∆8-Tetrahydrocannabinol (Delta-8-THC) Use (Journal of Cannabis Research, May 27, 2023)
Determinants of health-related quality of life among individuals with opioid use disorder, recently released from incarceration (Addiction Science and Clinical Practice, May 26, 2023)
Substance Use Disorders (SUDs) and Risk of Cardiovascular Disease (CVD) and Cerebrovascular Disease (CeVD) (Cureus, May 23, 2023)
Evidence-based whole-person care for pregnant people who have opioid use disorder (SAMHSA, May 23, 2023)
Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes (JAMA Network Open, May 20, 2023)
Research and Communication Key to Providing the Best Outcome for Cannabis Users During Surgery (Pain Medicine News, May 20, 2023)
Perioperative Management of Patients With Substance Use Disorders (Clinical Pain Medicine, May 20, 2023)
Nondisordered Cannabis Use Among US Adolescents (JAMA Network Open, May 19, 2023)
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation (Addiction Science and Clinical Practice, May 19, 2023)
The Risk of Misuse and Diversion of Buprenorphine for Opioid Use Disorder Appears to Be Low in Medicare Part D (US Department of Health and Human Services, May 18, 2023)
Methamphetamine-Induced Hypoglycemia: A Case Report and Literature Review (Cureus, May 18, 2023)
Relationship of gambling disorder with traumatic life events and emotion regulation in adolescents and young adults (Journal of Behavioral Addictions, May 18, 2023)
Efficacy of a Vibrating Crib Mattress to Reduce Pharmacologic Treatment in Opioid-Exposed Newborns (JAMA Pediatrics, May 15, 2023)
Rapid Analysis of Drugs: A Pilot Surveillance System to Detect Changes in the Illicit Drug Supply to Guide Timely Harm Reduction Responses (CDC, May 9, 2023)
Characteristics and impact of physical activity interventions during substance use disorder treatment excluding tobacco: A systematic review (PLOS ONE, May 9, 2023)
Subtypes in addiction and their neurobehavioral profiles across three functional domains (Translational Psychiatry, May 9, 2023)
Xylazine — Medical and Public Health Imperatives (New England Journal of Medicine, May 5, 2023)
Association between cannabis use disorder and schizophrenia stronger in young males than in females (Psychological Medicine, May 4, 2023)
United Nations Global Report on Cocaine 2023 (UN Office on Drugs and Crime, May 3, 2023)
Smoked cannabis reduces peak cocaine plasma levels and subjective effects in a controlled drug administration study (Drug and Alcohol Dependence, May 3, 2023)
The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review (Frontiers in Psychiatry, May 3, 2023)
Striatal ups or downs? Neural correlates of monetary reward anticipation, cue reactivity and their interaction in alcohol use disorder and gambling disorder (Journal of Behavioral Addictions, May 3, 2023)
Novel psychoactive substance: ADB-5’Br-PINACA (May 1, 2023)
Driving under the influence of substances and motor vehicle fatalities among older adults in the United States (Traffic Injury Prevention, April 30, 2023)
Association Between Acute Alcohol Use and Firearm-Involved Suicide in the United States (JAMA Network Open, April 27, 2023)
Operational definition of precipitated opioid withdrawal (Frontiers in Psychiatry, April 27, 2023)
Opioid overdose and harm reduction approaches to combat the looming crisis (Frontiers in Psychiatry, April 27, 2023)
Using the standard THC unit to regulate THC content in legal cannabis markets (Addiction, April 25, 2023)
Ingestion of Illicit Substances by Young Children Before and During the COVID-19 Pandemic (JAMA Network Open, April 24, 2023)
Prescription Stimulant Medical and Nonmedical Use Among US Secondary School Students, 2005 to 2020 (JAMA Network Open, April 20, 2023)
Women in psychiatry 2022: Addictive disorders (Frontiers in Psychiatry, April 20, 2023)
Editorial: Community series in neurobiological biomarkers for developing novel treatments of substance and non-substance addiction, volume II (Frontiers in Psychiatry, April 20, 2023)
A critical perspective on updating drug memories through the integration of memory editing and brain stimulation (Frontiers in Psychiatry, April 20, 2023)
FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use (U.S. Food and Drug Administration, April 15, 2023)
Direct/Conjugated Hyperbilirubinemia as an Uncommon Presentation of Acute Alcoholic Hepatitis: A Case Report (Cureus, April 15, 2023)
Substance use disorder bridge clinics: models, evidence, and future directions (Addiction Science and Clinical Practice, April 15, 2023)
Substance use in the past 12 months: Chicago, IL (NDEWS, April 14, 2023)
Characteristics of frequent and high-risk cannabis users (European Monitoring Centre on Drugs and Drug Addiction, April 12, 2023)
Prevalence of self-reported adverse effects associated with drug use among nightclub and festival attendees, 2019–2022 (Drug and Alcohol Dependence Reports, April 11, 2023)
Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique (Frontiers in Psychiatry, April 11, 2023)
Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses (Frontiers in Psychiatry, April 11, 2023)
Cannabidiol as an adjunct to OUD treatment (Frontiers in Psychiatry, April 11, 2023)
How have COVID-era Flexibilities Affected OUD treatment? (Foundation for Opioid Response Efforts, April 6, 2023)
State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019 (JAMA Psychiatry, April 6, 2023)
Association of Household Opioid Availability with Opioid Overdose (JAMA Network Open, April 4, 2023)
Responses to Novelty and Vulnerability to Cocaine Addiction: Contribution of a Multi-Symptomatic Animal Model (Cold Spring Harbor Perspectives in Medicine, April 1, 2023)
Craving in gambling disorder: A systematic review (Journal of Behavioral Addictions, March 31, 2023)
Alcohol, the overlooked drug: clinical pharmacist perspectives on addressing alcohol in primary care (Addiction Science and Clinical Practice, March 31, 2023)
Non-fatal drug overdoses: Short report (Drug Abuse Warning Network, March 31, 2023)
Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl (JAMA Network Open, March 30, 2023)
A contextualized reinforcer pathology approach to addiction (Nature, March 28, 2023)
Estimates and characteristics of non-fatal overdoses for ED visits from January, 2021–June, 2022 (SAMHSA/Drug Abuse Warning Network, March 27, 2023)
Availability of timely methadone treatment in the United States and Canada during COVID-19 (Drug and Alcohol Dependence, March 25, 2023)
Study design to evaluate a web-intervention to prevent alcohol and cannabis-impaired driving and use among adolescents in driver education (Addiction Science and Clinical Practice, March 25, 2023)
Alcohol and the Etiology of Depression (American Journal of Psychiatry, March 16, 2023)
Assessing compulsive sexual behavior disorder: The development and international validation of the compulsive sexual behavior disorder-diagnostic inventory (CSBD-DI) (Journal of Behavioral Addictions, March 15, 2023)
Association between clinical measures of unhealthy alcohol use and subsequent year hospital admissions in a primary care population (Drug and Alcohol Dependence, March 15, 2023)
State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019 (JAMA Psychiatry, March 15, 2023)
The concept of recovery in gaming disorder: A scoping review (Journal of Behavioral Addictions, March 15, 2023)
Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health (Frontiers in Psychiatry, March 14, 2023)
Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation (Frontiers in Psychiatry, March 14, 2023)
The role of substance use in the lives of incarcerated older adults: A qualitative study (Frontiers in Psychiatry, March 13, 2023)
Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study (Addiction Science and Clinical Practice, March 11, 2023)
Treatment effects and adherence of sexually compulsive men in a randomized controlled trial of psychotherapy and medication (Journal of Behavioral Addictions, March 11, 2023)
Amphetamine-Related Emergency Department Visits in Ontario, Canada, 2003-2020 (Canadian Journal of Psychiatry, March 10, 2023)
Drinking alcohol to cope with hyperactive ADHD? Self-reports vs. continuous performance test in patients with ADHD and/or alcohol use disorder (Frontiers in Psychiatry, March 9, 2023)
Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation (Frontiers in Psychiatry, March 8, 2023)
Incidence of Newborn Drug Testing and Variations by Birthing Parent Race and Ethnicity Before and After Recreational Cannabis Legalization (JAMA Network Open, March 8, 2023)
Quality of Opioid Use Disorder Treatment for Persons With and Without Disabling Conditions (JAMA Network Open, March 8, 2023)
Cannabidiol (CBD) – Potential harms, side effects and unknowns (SAMHSA, March 7, 2023)
Between a rock and a hard place? A 37-year-old man with acute liver injury while enrolled in a managed alcohol program for severe alcohol use disorder (Addiction Science and Clinical Practice, March 7, 2023)
High-Dose Buprenorphine Initiation in the Emergency Department Among Patients Using Fentanyl and Other Opioids (JAMA, March 3, 2023)
Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial (eClinical Medicine, March 3, 2023)
Cannabis use amongst tinnitus patients: consumption patterns and attitudes (Journal of Otolaryngology, February 28, 2023)
The involvement of spontaneous brain activity in natural recovery from internet gaming disorder: A resting-state fMRI study (Frontiers in Psychiatry, February 23, 2023)
Efficacy of a novel online integrated treatment for problem gambling and tobacco smoking: Results of a randomized controlled trial (Journal of Behavioral Addictions, February 22, 2023)
Digital interventions for substance use disorders in young people: rapid review (Substance Abuse Treatment, Prevention & Policy, February 21, 2023)
Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature (PLOS One, February 21, 2023)
2022 4th quarter DEA Toxicology Report (DEA, February 21, 2023)
Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations (Addiction Science and Clinical Practice, February 15, 2023)
A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians (Addiction Science and Clinical Practice, February 12, 2023)
Prevalence of Alcohol in Unintentional Opioid Overdose Deaths, 2017-2020 (JAMA Network Open, February 11, 2023)
Amphetamines modulate fentanyl-depressed respiration in a bidirectional manner (Drug and Alcohol Dependence, February 5, 2023)
Adverse Childhood Experiences Are Associated with History of Overdose Among Patients Presenting for Outpatient Addiction Care (Journal of Addiction Medicine, February 3, 2023)
Alcohol and Cannabinoids (Alcohol Research-Current Reviews, February 3, 2023)
Tobacco, Alcohol, Cannabis, and Other Drug Use in the US Before and During the Early Phase of the COVID-19 Pandemic (JAMA Open Network, February 3, 2023)
Widespread Distribution of Xylazine Detected Throughout the United States in Healthcare Patient Samples (Journal of Addiction Medicine, February 2, 2023)
A new series of 13 buprenorphine-related deaths (Clinical Biochemistry, February 2, 2023)
State Cannabis Legalization and Psychosis-Related Health Care Utilization (JAMA Open Network, January 30, 2023)
Initiation of and Escalation to High-Intensity Drinking in Young Adults (JAMA Pediatrics, January 30, 2023)
A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial (American Journal of Psychiatry, January 27, 2023)
FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors (Journal of Personalized Medicine, January 25, 2023)
Effects of a 7-Day Pornography Abstinence Period on Withdrawal-Related Symptoms in Regular Pornography Users: A Randomized Controlled Study (Archives of Sexual Behavior, January 21, 2023)
Sleep disorders as a prospective intervention target to prevent drug relapse (Frontiers in Psychiatry, January 21, 2023)
The impact of recreational cannabis markets on motor vehicle accident, suicide, and opioid overdose fatalities (Social Science and Medicine, January 20, 2023)
Opioids Prescribed to Adults at Discharge from Emergency Departments: United States, 2017–2020 (CDC, January 20, 2023)
NDEWS Hotspot Alerts January 12 – January 18, 2023: Opioid, heroin, methamphetamine, and non-opioid 911 dispatches (National Drug Early Warning System, January 20, 2023)
Cannabis and Public Health: A Study Assessing Regular Cannabis Users Through Health Indicators (Cannabis and Cannabinoid Research, January 17, 2023)
2021 National Survey of Drug Use and Health (NSDUH) (SAMHSA, January 11, 2023)
Findings from Drug-Related Emergency Department Visits, 2021 (SAMHSA, January 9, 2023)
The association between early onset of alcohol, smokeless tobacco and marijuana use with adult binge drinking in United States (Nature, January 6, 2023)
Pediatric Edible Cannabis Exposures and Acute Toxicity: 2017–2021 (Pediatrics, January 5, 2023)
Psychedelic Drug Legislative Reform and Legalization in the US (JAMA Psychiatry, January 5, 2023)
Recurrent Angina After Alcohol Consumption (JAMA Internal Medicine, January 4, 2023)
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial (eClinical Medicine) January 3, 2023)
Characteristics of Adults Aged ≥18 Years Evaluated for Substance Use and Treatment Planning — United States, 2019 (CDC, December 30, 2022)
Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults (JAMA Network Open, December 30, 2022)
Tobacco Use Remains High in Middle and High Schools (JAMA Network, December 28, 2022)
Gabapentin Will Not Cure the Opioid Crisis (JAMA Internal Medicine, December 27, 2022)
Illegal e-Cigarettes Targeting Youth (JAMA, December 22, 2022)
Warning About Xylazine, a Veterinary Sedative Found in Illicit Drugs (JAMA, December 22, 2022)
American Society of Addiction Medicine Advocacy Guide to Reducing Barriers to Lifesaving Treatment: Report on the Findings from ASAM’s Pharmacy Access Survey(American Society of Addiction Medicine, December 18, 2022)
DEA Disconnect Leads to Buprenorphine Bottlenecks (Abstract only, Journal of Addiction Medicine, December 18, 2022)
Association of a Positive Drug Screening for Cannabis with Mortality and Hospital Visits Among Veterans Affairs Enrollees Prescribed Opioids (JAMA Network Open, December 16, 2022)
Characteristics of poisonings involving ketamine in the United States, 2019–2021 (Journal of Psychopharmacology, December 16, 2022)
Drug Overdose Deaths Among Persons Aged 10–19 Years — United States, July 2019–December 2021 (CDC, December 16, 2022)
Adverse childhood experiences increase the risk for eating disorders among adolescents (Frontiers in Psychology, December 15, 2022)
Drug Overdose Deaths in Adults Aged 65 and Over: United States, 2000–2020 (CDC, December 14, 2022)
The genetic etiology of cannabis use: from twin models to genome-wide association studies and beyond (Translational Psychiatry, December 13, 2022)
Electronic cigarette or vaping use among adolescents in the United States: A call for research and legislative action (Frontiers in Public Health, December 13, 2022)
Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US (Molecular Psychiatry, December 13, 2022)
Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain (JAMA Network Open, December 12, 2022)
Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities—overview and commentary (Addiction Science and Clinical Practice, December 9, 2022)
Therapeutic use of psilocybin: Practical considerations for dosing and administration (Frontiers in Psychiatry, December 7, 2022)
Association of Prenatal Exposure to Benzodiazepines with Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders (JAMA Open Network, December 4, 2022)
Association of Benzodiazepine Treatment for Sleep Disorders with Drug Overdose Risk Among Young People (JAMA Open Network, December 4, 2022)
Provisional Drug Overdose Death Counts (National Vital Statistics System, December 4, 2022)
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder (JAMA Psychiatry, November 30, 2022)
Findings on neuropsychiatric symptoms caused by nitrous oxide abuse (Frontiers in Psychiatry, November 24, 2022)
Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder (JAMA Network Open, November 23, 2022)
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates (Addiction Science and Clinical Practice, November 23, 2022)
Massive intoxication due to cocaine adulterated with carfentanil (Toxicologie Analytique et Clinique, November 18, 2022)
Effect of Selective Personality-Targeted Alcohol Use Prevention on 7-Year Alcohol-Related Outcomes Among High-risk Adolescents (JAMA Pediatrics, November 18, 2022)
Death Rates for Drug Overdose Among Persons Aged 25–44 Years, by Race and Ethnicity— United States, 2000–2020 (CDC, November 17, 2022)
Association of Pharmacological Treatments and Hospitalization and Death in Individuals with Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients (JAMA Psychiatry, November 16, 2022)
The impact of the COVID-19 pandemic on addictive disorders—an update (Addiction, November 15, 2022)
OPIUM CULTIVATION IN AFGHANISTAN Latest findings and emerging threats (U.N. Office of Drug Control Policy, November 14, 2022)
Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002–2019 (Addictive Behaviors Reports, November 14, 2022)
Under-representation of key demographic groups in opioid use disorder trials (Drug and Alcohol Dependence Review, November 11, 2022)
Patterns in Geographic Distribution of Substance Use Disorder Treatment Facilities in the US and Accepted Forms of Payment From 2010 to 2021 (JAMA Open Network, November 11, 2022)
Tobacco Product Use Among Middle and High School Students — United States, 2022 (CDC, November 11, 2022)
Therapeutic management of buying/shopping disorder: A systematic literature review and evidence-based recommendations (Frontiers in Psychiatry, November 10, 2022)
Association of the COVID-19 Pandemic with Adolescent and Young Adult Eating Disorder Care Volume (JAMA Pediatrics, November 9, 2022)
Cannabis Use and PTSD Among Veterans (U.S. Veteran's Administration, November 9, 2022)
Alcohol use disorder with comorbid anxiety disorder: a case report and focused literature review (Addiction Science and Clinical Practice, November 9, 2022)
Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation (European Heart Journal, November 8, 2022)
Association Between Smoking, Smoking Cessation, and Mortality by Race, Ethnicity, and Sex Among US Adults (JAMA Network Open, November 8, 2022)
Performance Measurement for Opioid Use Disorder Medication Treatment and Care Retention (American Journal of Psychiatry, November 8, 2022)
Intestinal Ischemia Due to Methamphetamine Abuse in a Confused Elderly Patient: A Case Report (Cureus, November 7, 2022)
Suboxone: History, controversy, and open questions (Frontiers in Psychiatry, November 7, 2022)
Attitudes and training related to substance use in pediatric emergency departments(Addiction Science and Clinical Practice, November 4, 2022)
Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic (JAMA Network Open, November 4, 2022)
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (CDC, November 4, 2022)
Transforming Management of Opioid Use Disorder with Universal Treatment (New England Journal of Medicine, October 28, 2022)
Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review (Frontiers in Psychiatry, October 24, 2022)
Study protocol—Evoked craving in high-dose benzodiazepine users (Frontiers in Psychiatry, October 24, 2022)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (JAMA Psychiatry, October 19, 2022)
Cannabis Use Associated With Higher Sedation Doses for Gastroscopy (Pain Medicine News, October 14, 2022)
Antihistamine Positivity and Involvement in Drug Overdose Deaths (CDC, October 14, 2022)
The Continued Rise of Unintentional Ingestion of Edible Cannabis in Toddlers—A Growing Public Health Concern (JAMA Pediatrics, October 10, 2022)
Notes from the Field: E-cigarette Use Among Middle and High School Students — United States, 2022 (CDC, October 7, 2022)
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing (Addiction Science and Clinical Practice, October 5, 2022)
Relationship between marijuana use and Overactive Bladder(OAB) (American Journal of Medicine, September 28, 2022)
Effects of moderate-intensity exercise on social health and physical and mental health of methamphetamine-dependent individuals: A randomized controlled trial (Frontiers in Psychiatry, September 28, 2022)
Knowing and being known: Psychedelic–assisted psychotherapy and the sense of authenticity (Frontiers in Psychiatry, September 28, 2022)
Analysis of Substance Use Disorder Treatment Admissions in the US by Sex and Race and Ethnicity Before and During the COVID-19 Pandemic (JAMA Network Open, September 23, 2022)
Estimating the Prevalence of Substance Use Disorders in the US Using the Benchmark Multiplier Method (JAMA Psychiatry, September 22, 2022)
Effectiveness of a Stand-alone Telephone-Delivered Intervention for Reducing Problem Alcohol Use (JAMA Psychiatry, September 22, 2022)
Mandated Reporting of Perinatal Substance Use:The Root of Inequity (JAMA Pediatrics, September 19, 2022)
Provisional Drug Overdose Death Counts (CDC, September 16, 2022)
Perceptions of prevalence, consequences, and strategies for managing contraband substance use in an inpatient concurrent disorders program: A qualitative study of patient perspectives and survey of clinician perspectives (Frontiers in Psychiatry, September 13, 2022)
Gaming motivations and gaming disorder symptoms: A systematic review and meta-analysis (Journal of Behavioral Addictions, September 12, 2022)
Review: Cannabinoids as Medicinals(Cannabis, September 12, 2022)
Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department (International Journal of Emergency Medicine, September 12, 2022)
A review on the cannabinoids impacts on psychiatric disorders (Chemical Review and Letters, September 10, 2022)
Patient evaluation of a smartphone application for telehealth care of opioid use disorder (Addiction Science and Clinical Practice, September 10, 2022)
Treatments and interventions for compulsive sexual behavior disorder with a focus on problematic pornography use: A preregistered systematic review (Journal of Behavioral Addictions, September 9, 2022)
AMA 2022 Overdose Epidemic Report (AMA, September 9, 2022)
Growing Role of Gabapentin in Opioid-Related Overdoses Highlights Misuse Potential and Off-label Prescribing Practices (JAMA Network, September 7, 2022)
Symptoms of problematic pornography use among help-seeking male adolescents: Latent profile and network analysis (Journal of Behavioral Addictions, September 6, 2022)
Prescription opioid use in multiple sclerosis (British Medical Journal, September 6, 2022)
Association Between Changes in Alcohol Consumption and Cancer Risk (JAMA Open Network, September 5, 2022)
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial (Addiction Science and Clinical Practice, September 5, 2022)
Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence (Frontiers in Neurology, September 3, 2022)
Overdose deaths involving non-benzodiazepine hypnotic/sedatives in the USA: Trends analyses (The Lancet, September 3, 2022)
Hospital Standards of Care for People with Substance Use Disorder (New England Journal of Medicine, September 1, 2022)
Monitoring the Future Annual Report: Adults 19-60
A Case for Permanent Adoption of Expanded Telehealth Services and Prescribing Flexibilities for Opioid Use Disorder (JAMA Psychiatry, September 1, 2022)
Preparing for the Bursting of the Psychedelic Hype Bubble (JAMA Psychiatry, September 1, 2022)
Only 5% of Overdose Patients Tested for Fentanyl, #1 Killer of Americans 18-45 (Epic Research, August 31, 2022)
The HIV pre-exposure prophylaxis continuum of care among women who inject drugs: A systematic review (Frontiers in Psychiatry, August 30, 2022)
Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis (Addiction, August 29, 2022)
Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns (JAMA Network Open, August 27, 2022)
Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study (Addiction, August 26, 2022)
Patient-Level and County-Level Trends in Nonfatal Opioid-Involved Overdose Emergency Medical Services Encounters — 491 Counties, United States, January 2018–March 2022 (CDC, August 25, 2022)
Striatal dopamine dissociates methylphenidate effects on value-based versus surprise-based reversal learning (Nature Communications, August 25, 2022)
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients with Alcohol Use Disorder (JAMA Psychiatry, August 25, 2022)
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis (Healthcare, August 24. 2022)
Only 5% of Overdose Patients Tested for Fentanyl, #1 Killer of Americans 18-45 (Epic Research, August 23, 2022)
The Value of Knowing That a Patient Has Overdosed (JAMA Internal Medicine, August 23, 2022)
Cannabis and the Brain: Friend or Foe?
(In: Cannabinoids - Recent Perspectives and Applications in Human Health, August 23, 2022)
Percentage of overdose deaths involving methadone declined between January 2019 and August 2021 (NIDA, August 19, 2022)
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes (Addiction Science and Clinical Practice, August 16, 2022)
Trends in Binge Drinking and Heavy Alcohol Consumption Among Pregnant Women in the US, 2011 to 2020 (JAMA Open Network, August 16, 2022)
Association of Maternal Tobacco Use During Pregnancy with Preadolescent Brain Morphology Among Offspring (JAMA Open Network, August 16, 2022)
Adolescent Use of Flavored Non-Tobacco Oral Nicotine Products (Pediatrics, August 16, 2022)
Urine Drug Screens: The Addition of Routine Fentanyl Screening to Clinical Toxicology Panel (Legislative Analysis and Public Policy Association, August 16, 2022)
Association of Methamphetamine and Opioid Use with Nonfatal Overdose in Rural Communities (JAMA Open Network, August 16, 2022)
Hidden gender-based violence: Women and substance use (Frontiers in Psychiatry, August 16, 2022)
State resilience and rate of recovery among addicts: Moderating role of social skills (Frontiers in Psychiatry, August 16, 2022)
Editorial: Investigating substance use disorders using neuroimaging-based brain connectivity (Frontiers in Psychiatry, August 16, 2022)
Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016–2019 (Clinical Toxicology, August 15, 2022)
A Retrospective Study of the Adjunctive Use of Gabapentin with Benzodiazepines for the Treatment of Benzodiazepine Withdrawal(Journal of Psychiatric Practice, August 15, 2022)
Longitudinal Assessments of Neurocognitive Performance and Brain Structure Associated With Initiation of Tobacco Use in Children, 2016 to 2020 (JAMA Pediatrics, August 13, 2022)
Geographic Trends in Opioid Overdoses in the US From 1999 to 2020 (JAMA Open Network, August 12, 2022)
Notes From the Field: Overdose Deaths Involving Eutylone (Psychoactive Bath Salts) — United States, 2020 (CDC, August 11, 2022)
Case Report Highlighting Cardiovascular Effects of Concomitant Use of Methamphetamine and Marijuana (Cureus, August 11, 2022)
Cannabinoids - Recent Perspectives and Applications in Human Health (August 9, 2022)
Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users (Frontiers in Psychiatry, August 9, 2022)
Editorial: Dual disorders (addictive and concomitant psychiatric disorders): Mechanisms and treatment (Frontiers in Psychiatry, August 9, 2022)
Duration of the effectiveness of nicotine electronic cigarettes on smoking cessation and reduction: Systematic review and meta-analysis (Frontiers in Psychiatry, August 9, 2022)
Use of Electronic Cigarettes Among Cannabis-Naive Adolescents and Its Association With Future Cannabis Use (JAMA Open Network, August 8, 2022)
Illinois Youth Survey 2022 Results (August 9, 2022)
Legal review of state emergency medical services policies and protocols for naloxone administration (Drug and Alcohol Dependence, August 5, 2022)
Self-reported marijuana use and cardiac arrhythmias (American Journal of Cardiology, August 2, 2022)
Gamblers' use of measures to prevent gambling problems and reduce harm (Frontiers in Psychiatry, August 2, 2022)
Ketamine as a prophylactic resilience-enhancing agent (Frontiers in Psychiatry, August 2, 2022)
Factors Linked With Hazardous And Non- Hazardous Use of Cannabis Among College Students (International Journal of Early Childhood Special Education, August 2, 2022)
Addressing adolescent substance use with a public health prevention framework: the case for harm reduction (Annuals of Medicine, August 2, 2022)
Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 (The Lancet, July 24, 2022)
Optimizing internet-delivered cognitive behaviour therapy for alcohol misuse—a randomized factorial trial examining effects of a pre-treatment assessment interview and guidance (Addiction Science and Clinical Practice, July 24, 2022)
Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey (Social Science and Medicine, July 21, 2022)
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses from Opioid Treatment Programs (JAMA Psychiatry, July 21, 2022)
The serotonin theory of depression: a systematic umbrella review of the evidence (Molecular Psychiatry, July 21, 2022)
Quitline utilization and effectiveness trends among a large sample of tobacco users reporting mental health disorders (Frontiers in Psychiatry, July 21, 2022)
Online Sex Addiction: A Qualitative Analysis of Symptoms in Treatment-Seeking Men (Frontiers in Psychiatry, July 15, 2022)
Brain lesions disrupting addiction map to a common human brain circuit (Nature Medicine, July 13, 2022)
FACT SHEET: White House Releases 2022 National Drug Control Strategy
Gabapentin Increasingly Implicated in Overdose Deaths (JAMA, July 7, 2022)
Drug adulterants and their effects on the health of users: A critical review (Organization of American States, 2019)
Evaluation of the Trajectory of Depression Severity with Ketamine and Esketamine Treatment in a Clinical Setting (JAMA Psychiatry, July 7, 2022)
Suicide Attempt and Risk of Substance Use Disorders Among Female Youths (JAMA Psychiatry, July 7, 2022)
Preaddiction—A Missing Concept for Treating Substance Use Disorders (JAMA Psychiatry, July 6, 2022)
Association of Medication-Assisted Therapy with New Onset of Cardiac Arrhythmia in Patients Diagnosed with Opioid Use Disorders (American Journal of Medicine, July 6, 2022)
Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis (Science Advances, July 5, 2022
Right Inferior Frontal Activation During Alcohol-Specific Inhibition Increases With Craving and Predicts Drinking Outcome in Alcohol Use Disorder (Frontiers in Psychiatry, July 5, 2022)
Cannabinoids: Therapeutic Use in Clinical Practice (International Journal of Molecular Sciences, July 2, 2022)
Situating Psychopharmacology in Literature and Culture (Psychopharmacology in British Literature and Culture, July 2, 2022)
“The idea is to help people achieve greater success and liberty”: A qualitative study of expanded methadone take-home access in opioid use disorder treatment (Substance Abuse, July 1, 2022)
Substance Use Disorder Prevalence Rates Reported in Surveys Across Sociodemographic Groups in the Veterans Health Administration (JAMA Open Network, July 1, 2022)
Drug Overdose Deaths in 28 States and the District of Columbia: 2020 data from the State Unintentional Drug Overdose Reporting System (CDC, July 1, 2022)
A key requirement for synaptic Reelin signaling in ketamine-mediated behavioral and synaptic action (Biological Sciences, July 1, 2022)
Proceedings of the 17th Annual International INEBRIA ConferenceAddiction Science and Clinical Practice, June 30, 2022)
Meta-Analysis of Structural and Functional Brain Abnormalities in Cocaine Addiction (Frontiers in Psychiatry, June 28, 2022)
Medical cannabis and automobile accidents: Evidence from auto insurance (Health Economics, June 27, 2022)
Self-Control as Conceptual Framework to Understand and Support People Who Use Drugs During Sex (Frontiers in Public Health, June 23, 2022)
Brain lesions disrupting addiction map to a common human brain circuit (Nature, June 22, 2022)
A mobile-based pregaming drinking prevention intervention for college students: study protocol for a randomized controlled trial (Addiction Science and Clinical Practice, June 19, 2022)
Pharmacological Effects of Cannabinoids Extracted from Industrial hemp on Epilepsy (Journal of Pharmacology and Pharmaceutical Research, June 19, 2022)
Characteristics of Adults Aged ≥18 Years Evaluated for Substance Use and Treatment Planning — United States, 2019 (CDC, June 15, 2022)
Long-term Risk of Overdose or Mental Health Crisis After Opioid Dose Tapering (JAMA, June 15, 2022)
Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature (Journal of Pain Research, June 15, 2022)
Birth Outcomes of Neonates Exposed to Marijuana in Utero (JAMA, June 10, 2022)
Reexamining Medicaid Patient Review and Restriction Programs Amid the Evolving Opioid Epidemic (JAMA Internal Medicine, June 6, 2022)
Analysis of Urine Drug Test Results from Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020 (JAMA Open Network, June 3, 2022)
Jail-based treatment for opioid use disorder in the era of bail reform (Addiction Science and Clinical Practice, June 3, 2022)
Neural and behavioral correlates of sexual stimuli anticipation point to addiction-like mechanisms in compulsive sexual behavior disorder (Journal of Addictive Behaviors, June 1, 2022)
Preliminary Findings from Drug-Related Emergency Department Visits, 2021 (Drug Abuse Warning Network/SAMHSA, May 31, 2022)
Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial (Nature Medicine, May 31, 2022)
Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder (Frontiers in Psychiatry, May 31, 2022)
Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD (Psychopharmacology, May 30, 2022)
Estimation of the Prevalence of Delayed Dispensing Among Opioid Prescriptions from US Surgeons and Dentists (JAMA, May 28, 2022)
Categorization of Opioid Use Among Pregnant People and Association with Overdose or Death (JAMA, May 28, 2022)
Frequency of adolescent cannabis smoking and vaping in the United States: Trends, disparities and concurrent substance use, 2017–19. (Addiction, May 27, 2022)
The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects (Journal of Psychopharmacology, May 26, 2022)
Non-fentanyl-derived synthetic opioids emerging during recent years (Forensic Toxicology, May 26, 2022)
Complex Persistent Benzodiazepine Dependence—When Benzodiazepine Deprescribing Goes Awry (JAMA Psychiatry, May 25, 2022)
Targeting the Salience Network: A Mini-Review on a Novel Neuromodulation Approach for Treating Alcohol Use Disorder (Frontiers in Psychiatry, May 24, 2022)
Commission on Combating Synthetic Opioid Trafficking-Final Report (Rand Corporation, May 23, 2022)
Correlation between loneliness, personality traits, and treatment outcomes in patients with methamphetamine use disorder (Scientific Reports, May 23, 2022)
Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder (JAMA, May 20, 2022)
Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study (BMJ Open, May 17, 2022)
Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials (Environmental Research and Public Health, May 17, 2022)
Evaluation of Trends in Alcohol Use Disorder–Related Mortality in the US Before and During the COVID-19 Pandemic (JAMA Open Network, May 17, 2022)
Opioid and Naloxone Prescribing Following Insertion of Prompts in the Electronic Health Record to Encourage Compliance With California State Opioid Law (JAMA Open Network, May 17, 2022)
Alcohol and Health Outcomes: An Umbrella Review of Meta-Analyses Base on Prospective Cohort Studies (Frontiers in Psychology, May 17, 2022)
The Effects of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Smoking Behavior: An Ecological Momentary Assessment Study (Frontiers in Psychiatry, May 17, 2022)
Immune Therapy for Substance Use Disorders (Frontiers in Psychiatry, May 15, 2022).
Acute pediatric cannabis intoxication: A scoping review (Journal of Child Health, May 14, 2022)
Beyond the Waiver: Multilevel Interventions Needed to Expand Buprenorphine Treatment (JAMA, May 12, 2022)
Provisional Drug Overdose Death Counts (2021) (CDC, May 12, 2022)
Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use (JAMA OpenNetwork, May 9, 2022)
Emerging Agents of Substance Use/Misuse (Emergency Medical Clinics of North America, May 10, 2022)
Altered EEG Microstates Dynamics During Cue-Induced Methamphetamine Craving in Virtual Reality Environments (Frontiers in Psychiatry, May 10, 2022)
A Longitudinal Examination of Alcohol-Related Blackouts as a Predictor of Changes in Learning, Memory, and Executive Function in Adolescents (Frontiers in Psychiatry, May 10, 2022)
The Perceptions of Women About Their High Experience of Using Crack Cocaine (Frontiers in Psychiatry, May 5, 2022)
Feasibility of a computer-assisted social network motivational interviewing intervention to reduce substance use and increase supportive connections among emerging adults transitioning from homelessness to housing (Addiction Science and Clinical Practice, May 4, 2022)
Differences in problem and pathological gambling: A narrative review considering sex and gender (Journal of Behavioral Addictions, May 3, 2022)
Cannabis and Brain Health: What Is Next for Developmental Cohort Studies? (American Journal of Psychiatry< May 1, 2022)
Development of Goal Management Training+ for Methamphetamine Use Disorder (Frontiers in Psychiatry, April 28, 2022)
Association of Opioid Dose Reduction with Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy (JAMA, April 27, 2022)
The Effects of Cannabinoids on Sleep (Journal of Primary Care and Community Health, April 26, 2022)
Gender Differences in Cannabis Use Disorder Symptoms (Publication pre-print, April 26, 2022)
Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample (Nature Scientific Reports, April 22, 2022)
Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being (Frontiers in Psychiatry, April 13, 2022)
The History of Medical Cannabis (April 12, 2022)
Current Understanding of the Effects and Potential Clinical Utility of Kratom: A Review (Psychiatric Practice, April 11, 2022)
Factors Associated With Opioid Overdose After an Initial Opioid Prescription (JAMA Network Open, April 9, 2022)
Notes From the Field: Xylazine-Related Deaths — Cook County, Illinois, 2017–2021 (CDC, April 8, 2022)
Medical Cannabis and Past-Year Cannabis Use Disorder Among Adult Recreational Users in the United States (Frontiers in Psychiatry, April 6, 2022)
Case report: acute care management of severe opioid withdrawal with IV fentanyl (Addiction Science and Clinical Practice, April 6, 2022)
Patterns of and Rationale for the Co-use of Methamphetamine and Opioids (Frontiers in Psychiatry, April 5, 2022)
A critical review of cannabis in medicine and dentistry: A look back and the path forward (Clinical and Experimental Dental Research, April 4, 2022)
Association of Severity of Adolescent Substance Use Disorders and Long-term Outcomes (JAMA Open Network, April 1, 2022)
Drug use severity in adolescence affects substance use disorder risk in adulthood (JAMA Open Network, April 1, 2022)
Fine Particulate Matter Exposure From Secondhand Cannabis Bong Smoking (JAMA OpenNetwork, March 31, 2022)
Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021 (Drug and Alcohol Dependence, March 31, 2022. Abstract only)
Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis (Drug and Alcohol Dependence, March 30, 2022. Abstract only)
Cannabidiol (CBD) in the Self-Treatment of Depression (Frontiers in Psychiatry, March 29, 2022)
Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients (Frontiers in Psychiatry, March 29, 2022)
Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated(Frontiers in Psychiatry, March 29, 2022)
WHO Expert Committee on Drug Dependence Report 2022
(World Health Organization, March 25, 2022)
Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder (JAMA Network Open, March 20, 2022)
Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review (Brain Science, March 20, 2022)
Relationship Between Marijuana Use and Hospitalization for Acute Coronary Syndrome (Cureus, March 20, 2022)
Association Between Workplace Absenteeism and Alcohol Use Disorder (JAMA, March 18, 2022)
Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults(JAMA, March 18, 2022)
A narrative review of binge eating and addictive behaviors: shared associations with seasonality and personality factors (Frontiers in Psychiatry, March 18, 2022)
Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis (Drug amd Alcohol Dependence, abstract only, March 4, 2022)
How Academic Medicine Can Help Confront the Opioid Crisis (Academic Medicine, February 23, 2022)
Inherited Patients Taking Opioids for Chronic Pain — Considerations for Primary Care (New England Journal of Medicine, February 18, 2022)
A comprehensive study to delineate the role of an extracellular vesicle-associated microRNA-29a in chronic methamphetamine use disorder (Journal of Extracellular Versicles, February 16, 2022)
Therapy in the Age of Legalized Marijuana: A Qualitative Study of Counselors’ Experience in Responding to Patient Marijuana Use(American Journal of Qualitative Research, February 3, 2022)
Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum—20 years of research informing practice (Addiction Science and Clinical Practice, February 3, 2022)
Adolescent cannabis use and later development of schizophrenia: An updated systematic review of longitudinal studies (Journal of Clinical Psychology, February 3, 2022)
Intentional Drug Overdose Deaths in the United States(American Journal of Psychiatry, February 3, 2022)
Unintentional Drug Overdose Mortality in Years of Life Lost Among Adolescents and Young People in the US From 2015 to 2019 (JAMA Pediatrics, January 31, 2022)
Factors Associated With Opioid Overdose After an Initial Opioid Prescription(JAMA, January 28, 2022)
Driving Performance and Cannabis Users’ Perception of Safety(JAMA Psychiatry, January 27, 2022)
Overdose and Homelessness—Why We Need to Talk About Housing (JAMA Network Open, January 25, 2022)
Medical Cannabis Used as an Alternative Treatment for Chronic Pain Demonstrates Reduction in Chronic Opioid Use – A Prospective Study (Pain Physician, January 25, 2022)
Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial (Frontiers in Psychiatry, January 25, 2022)
Features of Psychotic Symptoms in Methamphetamine Use Disorder Patients and Ketamine Use Disorder Patients: A Cross-Sectional Study (Frontiers in Psychiatry, January 25, 2022)
Attenuated Psychotic Symptoms in Adolescents with Chronic Cannabis and MDMA Use (Frontiers in Psychiatry, January 25, 2022)
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures (Science Direct, January 21, 2022)
Adjunctive Ketamine with Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder (American Journal of Psychiatry, January 19, 2022)
Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging (Neuropsychopharmacology, January 19, 2022)
Proposed updates to the 4th Edition of The ASAM Criteria (ASAM, January 17, 2022)
2021 Q4 Report: Methamphetamine-related 911 EMS responses per 10k population, October 2021 – December 2021 (NIDA, January 14, 2022)
Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin Epidemics (Frontiers in Psychiatry, January 12, 2022)
Disparities by Sex and Race and Ethnicity in Death Rates Due to Opioid Overdose Among Adults 55 Years or Older, 1999 to 2019(JAMA Open Network, January 12, 2022)
Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor (Frontiers in Psychiatry, January 12, 2022)
Alcohol and Cannabis Use Disorders (American Journal of Psychiatry, January 12, 2022)
Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review (Frontiers in Psychiatry, January 12, 2022)
Monitoring the Future 2021 Survey Results (NIDA, January 10, 2021)
Unintentional Pediatric Cannabis Exposures After Legalization of Recreational Cannabis in Canada(JAMA Pediatrics, January 9, 2022)
Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls — United States, 2019–2020 (CDC MMWR, January 6, 2022)
Psychotropic Drug Use in Children and Adolescents Before and During the COVID-19 Pandemic (JAMA Pediatrics, January 6, 2022)
Vitamin D deficiency exacerbates UV/endorphin and opioid addiction (Science Advances, January 5, 2022)
Use of YouTube as a Source of Information for Quitting or Cutting Down Alcohol (Frontiers in Public Health, January 4, 2021)
Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls — United States, 2019–2020 (CDC MMWR, December 29, 2021)
Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Non-addiction Clinics in the US Veterans Health Care System (JAMA OpenNetwork, December 29, 21)
Emergency department-initiated buprenorphine protocols: A national evaluation (JACEP Open, December 29, 2021)
Expert Panel Consensus on Management of Advanced Cancer–Related Pain in Individuals with Opioid Use Disorder (JAMA OpenNetwork, December 29, 2021)
Substance-Induced Psychoses: An Updated Literature Review (Frontiers in Psychiatry, December 28, 2021)
Neurobiological Biomarkers for Developing Novel Treatments of Substance and Non-substance Addiction (Frontiers in Psychiatry, December 28, 2021)
Prescription stimulant misuse and prevention among youth and young adults (SAMHSA, December 21, 2021)
Combustible and electronic cigarette use and insufficient sleep among U.S. high school students (Preventative Medicine, December 13, 2021)
Age- and Sex-Related Cortical Gray Matter Volume Differences in Adolescent Cannabis Users (Frontiers in Psychiatry, December 7, 2021)
Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder (Frontiers in Psychiatry, December 7, 2021)
Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism(Science Advances, November 26, 2021
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply (ScienceDirect, November 23, 2021)
Attachment and Therapeutic Alliance in Substance Use Disorders: Initial Findings for Treatment in the Therapeutic Community (Frontiers in Psychiatry, November 19, 2021)
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review (Addiction Science and Clinical Practice, November 14, 2021)
Impact of Medication for Opioid Use Disorder on Symptoms of Depression (ATTC Network, November 12, 2021)
Using the Cascade of Care to Increase Use of Medication for Opioid Use Disorder in Criminal Justice Populations (ATTC Network, November 12, 2021)
Treatment Improvement Procol 21: Treating Stimulant Use Disorders (Revised) (SAMHSA, November 12, 2021)
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder (Nature, November 11, 2021)
Drug dependence is not addiction-and it matters (Annuals of Medicine, November 11, 2021)
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis (Addiction Science and Clinical Practice, November 11, 2021)
Incidence of Cigarette Smoking Relapse Among Individuals Who Switched to e-Cigarettes or Other Tobacco Products (JAMA Open Network, November 8, 2021)
Current Marijuana Use and Alcohol Consumption Among Adults Following the Legalization of Nonmedical Retail Marijuana Sales — Colorado, 2015–2019 (CDC, November 4, 2021)
Cannabis and COVID-19: Reasons for Concern (Frontiers in Psychiatry, November 3, 2021)
Acute Effects of Cannabis Concentrate on Motor Control and Speed: Smartphone-Based Mobile Assessment (Frontiers in Psychiatry, November 3, 2021)
2020 National Survey on Drug Use and Health (SAMHSA, November 1, 2021)
United Nations Toolkit on Synthetic Drugs (United Nations, November 1, 2021)
Addressing the Methamphetamine Crisis Before it Gets Worse(October 29, 2021)
Current Addiction in Youth: Online Sports Betting (Frontiers in Psychiatry, October 27, 2021)
Prevalence of Adolescent Cannabis Vaping Doubles in 7 years with potentially negative consequences(JAMA Pediatrics, October 26, 2021)
Altered Neural Processing of Reward and Punishment in Women With Methamphetamine Use Disorder (Frontiers in Psychiatry, October 23, 2021)
Type D Personality, Stress Level, Life Satisfaction, and Alcohol Dependence in Older Men (Frontiers in Psychiatry, October 23, 2021)
Preventing Marijuana Use Among Youth(SAMHSA free publication, October 17, 2021)
CDC Provisional Drug Overdose Death Counts (October 13, 2021)
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial(Addiction Science and Clinical Practice, October 13, 2021)
The stock market as a casino: Associations between stock market trading frequency and problem gambling (Journal of Behavioral Addictions, October 12, 2021)
Working at home and alcohol use (Addictive Behaviors Report, October 12, 2021)
Severe Encephalatrophy and Related Disorders From Long-Term Ketamine Abuse (Frontiers in Psychiatry, October 5, 2021)
Medical Cannabis as Adjunctive Therapy for Head and Neck Cancer Patients (Cureus, September 30, 2021)
Moving Toward Health and Social Equity for Women Who Use Cannabis During Preconception, Pregnancy, and Lactation (JAMA, September 27, 2021)
Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults (JAMA Psychiatry, September 23, 2021)
Respiratory failure in confirmed synthetic cannabinoid overdose (Clinical Toxicology, September 17, 2021)
Xylazine Detection and Involvement in Drug Overdose Deaths — United States, 2019 (CDC, September 17, 2021)
Increases in Availability of Cannabis Products Containing Delta-8 THC and Reported Cases of Adverse Events (CDC, September 15, 2021)
Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience Perspective (Frontiers in Psychiatry, September 13, 2021)
Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial (Frontiers in Psychiatry, September 13, 2021)
Changes in craving following acute aerobic exercise in adults with alcohol use disorder (Journal of Psychiatric Research, September 7, 2021)
NIH-funded study finds overall rate of drug use among 10-14 year-olds remained stable during the 2020 COVID-19 pandemic (NIDA, September 1, 2021)
Context dependent differences in working memory related brain activity in heavy cannabis users (Psychopharmacology, August 31, 2021)
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth (JAMA Open Network, August 29, 2021)
2021 Chicago Mid-Year Opioid Report (August 28, 2021)
Trends in Nonfatal and Fatal Overdoses Involving Benzodiazepines — 38 States and the District of Columbia, 2019–2020 (CDC, August 27, 2021)
Illicit Benzodiazepines Detected in Patients Evaluated in Emergency Departments for Suspected Opioid Overdose — Four States, October 6, 2020–March 9, 2021 (CDC, August 27. 2021)
Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature (Cureus, August 25, 2021)
Preliminary study of alcohol problem severity and response to brief intervention (Addiction Science and Clinical Practice, August 25, 2021)
Bupropion and Naltrexone in Methamphetamine Use Disorder (New England Journal of Medicine, August 23, 2021)
Efficacy of Cannabidiol for ∆-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review (Journal of Clinical Medicine, August 22, 2021)
Opioid exposure associated with poppy consumption reported to poison control centers and the U.S. Food and Drug Administration (Clinical Toxicology, August 22, 2021)
“This Is Something That Changed My Life”: A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders (Frontiers in Psychiatry, August 19, 2021)
A Systematic Review of Opioid Use Disorder and Related Biomarkers (Frontiers in Psychiatry, August 17, 2021)
Prescription Drug Monitoring Programs: Effects On Opioid Prescribing And Drug Overdose Mortality(American Council on Science and Health, August 14, 2021)
Early, Chronic, and Acute Cannabis Exposure and Their Relationship With Cognitive and Behavioral Harms (Frontiers in Psychiatry, August 12, 2021)
Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice (Frontiers in Psychiatry, August 12, 2021)
Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines (JAMA Network Open, August 8, 2021)
Racial/ethnic equity in substance use treatment research: the way forward (Addiction Science and Clinical Practice, August 6, 2021)
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures (International Journal of Drug Policy, August 6, 2021)
Effect of Graphic Warning Labels on Cigarette Packs on US Smokers’ Cognitions and Smoking Behavior After 3 Months (JAMA Open Network, August 5, 2021)
Impact of Warning Pop-Up Messages on the Gambling Behavior, Craving, and Cognitions of Online Gamblers (Frontiers in Psychiatry, July 27, 2021)
Racial disparities in criminal legal system involvement among New York City overdose decedents: Implications for diversion programs (Drug and Alcohol Dependence, July 26, 2021)
Cannabis Use Among Mental Health Professionals: A Qualitative Study of Cannabis-Related Risk Perceptions (Journal of Drug Issues, July 24, 2021)
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada(JAMA Network Open, July 24, 2021)
High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder (JAMA Network Open, July 16, 2021)
Decreasing Psychiatric Emergency Visits, but Stable Addiction Emergency Visits, During COVID-19 (Frontiers in Psychiatry, July 15, 2021)
How Do Specific Social Supports Reduce Stress in Patients With Substance Use Disorders: A Multiple Mediation Analysis (Frontiers in Psychiatry, July 13, 2021)
The Effects of Cannabis Use Frequency and Episodic Specificity Training on the Recall of Specific and Rewarding Events (Frontiers in Psychiatry, July 13, 2021)
Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? (Addiction, July 10, 2021)
Drug-Related Deaths Among U.S. Infants (CDC, July 8, 2021)
Decision Making and Impulsivity in Young Adult Cannabis Users (Frontiers in Psychology, July 7, 2021)
Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder: A Phase I Randomized Clinical Trial (Frontiers in Psychiatry, July 6, 2021)
Difference in Response to Feedback and Gender in Three Therapeutic Community Units (Frontiers in Psychiatry, July 6, 2021)
Financial sustainability of payment models for office-based opioid treatment in outpatient clinics(Addiction Science and Clinical Practice, July 6, 2021)
Alveolar hemorrhage due to marijuana smoking using water pipe made with plastic bottle: case report and narrative review of the literature (Inhalation Toxicology, July 6, 2021)
Sociodemographic changes in emergency department visits due to alcohol during COVID-19 (Drug and Alcohol Dependence, July 2, 2021)
CDC Provisional Drug Overdose Death Counts(July 2, 2021)
The Biden-Harris Administration’s Statement of Drug Policy Priorities for Year One
An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches (Frontiers in Psychiatry, June 29, 2021)
Metonitazene in the United States—Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry (Analytic Science Advances, June 25, 2021)
Association of Cannabis Use During Adolescence With Neurodevelopment (JAMA Psychiatry, June 20, 2021)
Listen to author interview here
Trends in Cannabis-Related Acute Psychosis Diagnoses in California-Based Emergency Departments(June 18, 2021)
Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs (Frontiers in Psychiatry, June 16, 2021)
Psychedelic-Assisted Psychotherapy and Carl Jung’s Red Book(JAMA Psychiatry, June 16, 2021)
Your Words Matter – Language Showing Compassion and Care for Women, Infants, Families, and Communities Impacted by Substance Use Disorder (NIDA, June 14, 2021)
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review (Addiction Science and Clinical Practice, June 9, 2021)
Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics (JAMA Open Network, June 7, 2021)
Transcutaneous Auricular Neurostimulation (tAN™) To Aid In The Reduction Of Symptoms Associated With Opioid Withdrawal (June 3, 2021)
Treatment of Patients With Anorexia Nervosa in the US—A Crisis in Care (JAMA Psychiatry, June 3, 2021)
From heavy cannabis use to psychosis: is it time to take action?(Irish Journal of Psychological Medicine, June 2, 2021)
Incidence and Lethality of Suicidal Overdoses by Drug Class (JAMA OpenNetwork, June 1, 2021)
Cannabis Use and Car Crashes: A Review (Frontiers in Psychiatry, June 1, 2021)
National Roadmap on State-Level Efforts to End the Nation’s Drug Overdose Epidemic(American Medical Association/Manatt Health, May 30, 2021)
Should screening for risk gambling be undertaken more widely?(Addiction Science and Clinical Practice, May 30, 2021)
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis (Current Opinion in Psychiatry, May 28, 2021)
Comments To The FDA: Opioid Dosing Based On Milligram Morphine Equivalents Is Unscientific (American Council on Science and Health, May 26, 2021)
Facilitating rapid access to addiction treatment: a randomized controlled trial (Addiction Science and Clinical Practice, May 26, 2021)
Trends and Characteristics of Manufactured Cannabis Product and Cannabis Plant Product Exposures Reported to US Poison Control Centers, 2017-2019 (JAMA OpenNetwork, May 26, 2021)
Functional Connectivity of Nucleus Accumbens and Medial Prefrontal Cortex With Other Brain Regions During Early-Abstinence Is Associated With Alcohol Dependence and Relapse: A Resting-Functional Magnetic Resonance Imaging(Frontiers in Psychiatry, May 25, 2021
Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics(JAMA OpenNetwork, May 23, 2021)
An Inexpensive Intervention to Reduce e-Cigarette Use Among Young Adults(JAMA Internal Medicine, May 22, 2021)
Illegal Pill Presses, an Overlooked Threat to American Patients(May 19, 2021)
The Abuse Characteristics of Amphetamine-Type Stimulants in Patients Receiving Methadone Maintenance Treatment and Buprenorphine Maintenance Treatment (Drug Design, Development and Therapy, May 18, 2021)
Cannabis Affects Cerebellar Volume and Sleep Differently in Men and Women (Frontiers in Psychiatry, May 18, 2021)
Comment on “Cannabis and the Environment: What Science Tells Us and What We Still Need to Know” (Environmental Science and Technology, Mat 11, 2021)
Sex and dependence related neuroanatomical differences in regular cannabis users (Translational Psychiatry, May 11, 2021)
Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries(Frontiers in Psychiatry, May 3, 2021)
The associations between prenatal cannabis use disorder and neonatal outcomes (Addiction, May 1, 2021-Abstract only)
Federal Register: Public Inspection: Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder (April 27, 2021)
Illinois Opioid Overdose Epidemic During the COVID-19 Pandemic (Illinois Department of Public Health, April 16, 2021)
Toxic Nightlife Relationships, Substance Abuse, and Mental Health: Is There a Link? (Frontiers in Psychiatry, April 14, 2021)
A Serious Game to Improve Emotion Regulation in Treatment-Seeking Individuals With Gambling Disorder (Frontiers in Psychology, April 14, 2021)
Buprenorphine Opioid Treatment During the COVID-19 Pandemic(JAMA Internal Medicine, April 12, 2021)
What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review ( PORTO Biomedical Journal, April 12, 2021)
Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder(Translational Psychiatry, April 11, 2021)
If there were an effective pharmacotherapy for cocaine use disorder, what would it do?(Addiction, April 11, 2021)
Will hope triumph over experience in pharmacotherapy research on cocaine use disorder? (Addiction, April 11, 2021) Related: Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer? (Addiction, April 11, 2021/abstract only)
Attitudes and beliefs about medical cannabis among social work students: Cross-national comparison(Complementary Therapies in Medicine, April 11, 2021)
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19(JAMA Psychiatry, April 8, 2021)
Assessment of Annual Cost of Substance Use Disorder in US Hospitals(JAMA Open Network, April 4, 2021)
Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease (JAMA Open Network, March 24, 2021)
Cognitive Development and Cannabis Use in Adolescents (Behavioral Sciences, March 23, 2021)
Internet Claims on the Health Benefits of Cannabis Use(Journal of General Internal Medicine, March 23, 2021)
Decision-Making in Ambiguous Situations Influences OUD Patients’ Relapse Risk (NIDA Notes, March 10, 2021)
Terpenes/Terpenoids in Cannabis: Are They Important? (Medical Cannabis and Cannabinoids, March 8, 2021)
Interventions to Address the Opioid Crisis—Modeling Predictions and Consequences of Inaction (JAMA Open Network, March 7, 2021)
Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution (Journal of Cannabis Research, March 2, 2021)
Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events (JAMA Open Network, February 24, 2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial (JAMA Psychiatry, February 24, 2021)
Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review (Frontiers in Psychiatry, February 23, 2021)
Inhibitory Control and Craving in Dual Disorders and Recurrent Substance Use (Frontiers in Psychiatry, February 11, 2021)
Prevalence and Co-occurrence of Alcohol, Nicotine, and Other Substance Use Disorder Diagnoses Among US Transgender and Cisgender Adults (JAMA OpenNetwork, February 11, 2021)
Nobody Wants to Be Narcan’d: A Pilot Qualitative Analysis of Drug Users’ Perspectives on Naloxone(Western Journal of Emergency Medicine, February 9, 2021)
Assessment of Prescription Opioid Medical Use and Misuse Among Parents and Their Adolescent Offspring in the USJAMA Open Network, February 7, 2021)
Impact of an unsanctioned safe consumption site on criminal activity, 2010–2019(Drug and Alcohol Dependence, February 5, 2021)
The Current Status of Psychedelics in Psychiatry(JAMA Psychiatry, February 4, 2021)
Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine(ACS Pharmacology and Tranlational Science, February 2, 2021)
Intelligence quotient decline following frequent or dependent cannabis use in youth: A systematic review and meta-analysis of longitudinal studies (Psychological Medicine, January 31, 2021)
“Some People Smoke and Drink, I Run”: Addiction to Running through an Ethnographic Lens (Leisure Sciences, January 31, 2021)
Increased Likelihood of Falling in Older Cannabis Users vs. Non-Users (Brain Sciences, January 25, 2012)
Metonitazene Begins Proliferation as Newest Synthetic Opioid Among Latest Cycle of Non-Fentanyl Related Drugs(NPS Discovery, January 25, 2021)
Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases (PLOS ONE, January 25, 2021)
Methamphetamine exposures reported to United States poison control centers, 2000–2019 (Clinical Toxicology, January 22, 2021)
Multiple clinical risks for cannabis users during the COVID-19 pandemic(Addiction Science and Clinical Practice, January 21, 2021)
Association of Cannabis Use With Self-harm and Mortality Risk Among Youths With Mood Disorders (JAMA Pediatrics, January 20, 2021)
How Resilience Promotes Mental Health of Patients With DSM-5 Substance Use Disorder(Frontiers in Psychiatry, January 19, 2021)
Assessing and Addressing Synthetic Cannabinoids and Cathinones in Neuropsychiatric Toxicological Emergencies (Psychiatric Times, January 17, 2021)
National Roadmap on State-Level Efforts to End the Nation’s Drug Overdose Epidemic (American Medical Association, January 16, 2021)
Association of Heavy Drinking With Deviant Fiber Tract Development in Frontal Brain Systems in Adolescents (JAMA Psychiatry, January 13, 2021)
Cannabis use while trying to conceive: a prospective cohort study evaluating associations with fecundability, live birth and pregnancy loss(Human Reproduction, January 13, 2021)
Consideration of Adolescent Pain in Responses to the Opioid Crisis (JAMA Psychiatry, January 7, 2021)
Preliminary Drug Abuse Warning Network Data Review (January 5, 2021)
Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-level differences and the role of opioids(Drug and Alcohol Dependence, January 1, 2021)
Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review(Journal of Clinical Medicine, December 28, 2020)
Medical management of eating disorders: an update(Current Opinion in Psychiatry, December 27, 2020)
Monitoring the Future Study: Trends in Prevalence of Various Drugs (December 26, 2020)
Canadian Cannabis Survey 2020: Summary(December 22, 2020)
The Importance of Studying Sex and Gender Differences in Opioid Misuse (JAMA Network Open, December 20, 2020)
Rate of Second Primary Head and Neck Cancer With Cannabis Use(Cureus, December 18, 2020)
Post-Legalization Changes in Marijuana Use in a Sample of Young California Adults(Abstract and summary, Addictive Behavior, December 18, 2020)
Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic (CDC Health Advisory, December 18, 2020)
Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015 (JAMA Psychiatry, December 10, 2020)
A study of the effectiveness of naltrexone in preventing recurrence of methadone poisoning in opioid-naive children(Physician's Weekly, December 10, 2020)
Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails (JAMA Psychiatry, December 9, 2020)
(Alcoholism: Clinical and Experimental Research, December 8, 2020)
Adverse childhood experiences are associated with at-risk drinking, cannabis and illicit drug use in females but not males: an Emergency Department study(American Journal of Drug and Alcohol Abuse, December 8, 2020)
An Inside Look at Depression Treatment Among Patients With Addictive Disorders(Psychiatric Times, December 4, 2020)
Increase of Emergency Department Admittance Due to Amphetamine-Type Stimulant Overdoses in the United States (Psychiatric Advisor, November
17, 2020)
Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial (JAMA, November 6, 2020)
Does cannabis alleviate tinnitus? A review of the current literature(Investigative Otolaryngology, November 5, 2020)
Is the Long-Term Use of Benzodiazepines Associated With Worse Cognition Performance in Highly Educated Older Adults? (Frontiers in Psychiatry, November 4, 2020)
Depression, Environmental Reward, Coping Motives and Alcohol Consumption During the COVID-19 Pandemic (Frontiers in Psychiatry, November 4, 2020)
Childhood Trauma, Emotion Regulation, and Pain in Individuals With Alcohol Use Disorder(Frontiers in Psychiatry, November 4, 2020)
Issue brief: Reports of increases in opioid- and other drug-related overdose and other concerns during COVID pandemic (JAMA, October 26, 2020)
Redoubling efforts to help Americans quit smoking: Federal initiatives to tackle America's long-running epidemic (New England Journal of Medicine, October 22, 2020)
Continuous High Frequency Deep Brain Stimulation of the Rat Anterior Insula Attenuates the Relapse Post Withdrawal and Strengthens the Extinction of Morphine Seeking(Full-text paper from Frontiers in Psychiatry, October 20, 2020)
Assessment of Changes in Alcohol and Marijuana Abstinence, Co-Use, and Use Disorders Among US Young Adults From 2002 to 2018(Abstract from JAMA Pediatrics, October 20, 2020)
Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance(Full-text paper from Drug and Alcohol Dependence, October 8, 2020)
Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties (Full-text paper, Journal of Translational Medicine, October 2, 2020)
Unidentified Dangerous Substance Distributed in “Trashcan” Containers Tied to ED Patients with Combative Behavior In Maryland (October 1, 2020)
Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health (Frontiers in Psychiatry, September 29, 2020)
Commentary: Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Impulse Inhibition Methamphetamine in Abstinent Methamphetamine Patients (Frontiers in Psychiatry, September 29, 2020)
American Academy of Neurology position paper on the use of medical marijuana for neurologic disorders (September 29, 2020)
Phenibut Addiction in a Patient with Substance Use Disorder(Cureus, September 25, 2020)
Notes from the Field: Phenibut Exposures Reported to Poison Centers — United States, 2009–2019(CDC Report, September 25, 2020)
Medical Marijuana, Recreational Cannabis, and Cardiovascular Health(A Scientific Statement From the American Heart Association, September 24, 2020)
AMA Issue brief: Reports of increases in opioid-related overdose and other concerns during COVID pandemic (September 24, 2020)
The Opioid Epidemic During the COVID-19 Pandemic(Editorial, JAMA, September 18, 2020)
Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health(September 18, 2020)
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States(Full-text report from Nature Molecular Psychiatry, September 18, 2020)
National Forensic Laboratory Information System 2019 Annual Report (September 17, 2020)
Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence? (Journal of Addiction Medicine [abstract only] September 14, 2020)
Mid-year Chicago opioid update (Chicago Department of Public Health, September 14, 2020)
E-cigarette Use Among Middle and High School Students — United States, 2020(CDC Report, September 11, 2020)
COVID-19, Medication-Assisted Treatment, and Increased Risk for Further Respiratory Depression(American Journal of Psychiatry, September 3, 2020)
Balancing the Public Health Costs of Psychosis vs Mass Incarceration With the Legalization of Cannabis(JAMA Network, September 3, 2020)
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19 (Full text article, JAMA Psychiatry, September 2, 2020)
Psychological factors associated with substance use initiation during the COVID-19 pandemic(Full text paper in Psychiatry Research, August 28, 2020)
Association of Depression With Past-Month Cannabis Use Among US Adults Aged 20 to 59 Years, 2005 to 2016(JAMA Open Network, August 20,2020)
Gender Differences in Sleep Problems Among Drug Users(Frontiers in Psychiatry, August 19, 2020)
Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020(CDC, August 14, 2020)
Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress Disorder(Journal of Affective Disorders, August 13, 2020)
Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease(JAMA Network Open, August 13, 2020)
Women and alcohol (Alcohol Research Current Reviews, August 13, 2020)
Direct Marketing Experiences Among Individuals With Current and Lifetime Gambling Disorder (Frontiers in Psychology, August 12, 2020)
Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults(US Preventive Services Task Force Recommendation Statement, August 10, 2020)
Highlights from 2020 National Drug Early Warning System "Sentinel Community Site" Reports (August 10, 2020)
Critical Illness Secondary to Synthetic Cannabinoid Ingestion (JAMA Open Network, August 8, 2020)
Association of Maternal Opioid Use in Pregnancy With Adverse Perinatal Outcomes in Ontario, Canada, From 2012 to 2018 (JAMA Open Network, August 8, 2020)
Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication (JAMA Open Network, August 9, 2020)
A Comparison of the Alpha-2-Adrenergic Receptor Agonists for Managing Opioid Withdrawal (Practical Pain Management, August 3, 2020)
An evaluation of food addiction as a distinct psychiatric disorder (International Journal of Eating Disorders, August 1, 2020)
Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial (Addiction Science and Clinical Practice, August 1, 2020)
What constitutes “behavioral health”? Perceptions of substance-related problems and their treatment in primary care(Addiction Science and Clinical Practice July 30, 2020)
Treating Eating: A Dynamical Systems Model of Eating Disorders (Frontiers in Psychology, July 30, 2020)
Study protocol for a group-based motivational interviewing brief intervention to reduce substance use and sexual risk behavior among young adults experiencing homelessness(Addiction Science and Clinical Practice, July 29, 2020)
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry (FDA July 22, 2020)
Psychedelic Research and the Need for Transparency: Polishing Alice’s Looking Glass(Frontiers in Psychology, July 21, 2020)
Neuropsychophysiological Measures of Alcohol Dependence: Can We Use EEG in the Clinical Assessment of AUD?(Frontiers in Psychiatry, July 21, 2020)
Depressive Disorder After Single Nitrous Oxide Inhalation Treatment (Frontiers in Psychiatry, July 21, 2020)
Exploring perspectives on chronic obstructive pulmonary disease in people who smoke heroin: a qualitative study (Royal College General Practitioners, July 17, 2020)
2019 Provisional Drug Overdose Death Counts(CDC, July 16, 2020)
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone(Full-text paper from Addiction Science and Clinical Practice, July 12, 2020)
Chronic Use of Synthetic Cannabinoids Is Associated With Impairment in Working Memory and Mental Flexibility (Full-text paper from Frontiers in Psychiatry, July 7, 2020)
Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting(Full-text paper from Frontiers in Psychiatry, July 7, 2020)
The Effects of Recreational Cannabis Access on the Labor Market: Evidence from Colorado(July 6, 2020)
The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression (Full-text paper from the Yale Journal of Biological Medicine, July 5, 2020)
4F-MDMB-BICA, a novel synthetic cannabinoid(July 1, 2020)
Association of Low to Moderate Alcohol Drinking With Cognitive Functions From Middle to Older Age Among US Adults (JAMA Open Network, June 30, 2020)
The Impact of Cannabidiol on Psychiatric and Medical Conditions(Full-text paper from Journal of Clinical Medical Research, June 29, 2020)
HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics (From September 2019)
State approaches to tackling the opioid crisis through the health care system(Brookings Institute June 23, 2020)
Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress Disorder (Abstract in Journal of Affective Disorders June 23, 2020)
A Structural Competency Curriculum for Primary Care Providers to Address the Opioid Use Disorder, HIV, and Hepatitis C Syndemic (Frontiers in Public Health, June 23, 2020)
Preventing opioid misuse and addiction: New thinking and the latest evidence(Brookings Institute June 22, 2020)
Association of Recreational Cannabis Laws in Colorado and Washington State With Changes in Traffic Fatalities, 2005-2017(Free full-text paper from JAMA Internal Medicine, June 22, 2020)
Attenuated reward activations associated with cannabis use in anxious/depressed individuals (Full-text paper in Transitional Psychiatry, June 21, 2020)
Counselling adolescents and parents about cannabis: A primer for health professionals (Full-text paper in Pediatrics and Child Health, June 21, 2020)
Cannabis vaping: Understanding the health risks of a rapidly emerging trend (Full-text paper in Pediatrics and Child Health, June 21, 2020)
Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis(JAMA Open Network full-text paper, June 19, 2020)
Haga clic aquí para la versión en Español
Status of State Marijuana Legalization June 2020(June 19, 2020)
Long-term Depression in the Nucleus Accumbens: A Neural Correlate of Behavioral Sensitization to Cocaine(Nature Neuroscience abstract, June 18, 2020)
Association of the US Outbreak of Vaping-Associated Lung Injury With Perceived Harm of e-Cigarettes Compared With Cigarettes(JAMA Open Network, June 18, 2020)
Treatment of Stimulant Use Disorders (New from SAMHSA June 17, 2020)
Heroin Adulterated with the Novel Synthetic Cannabinoid, 5F-MDMB-PINACA: A Case Series (Full-text paper in Clinical Practice Cases in Emergency Medicine, June 16, 2020)
(JAMA Pediatrics full text paper, June 16, 2020)
(Abstract in American Journal of Psychiatry, June 15, 2020)
Read the editorial here
Read a commentary here
Screening for Unhealthy Drug Use Neither an Unreasonable Idea Nor an Evidence-Based Practice (Journal of the American Medical Association article abstract, June 12, 2020)
The Rise and Fall of the Cocaine High/ El Alza y la Baja de la Euforia Causada por la Cocaína (June 11, 2020)
Electrochemical Oxidation of Δ9 -Tetrahydrocannabinol: A Simple Strategy for Marijuana Detection(May 20, 2020)
COVID-19 in Correctional and Detention Facilities — United States, February–April 2020 (CDC Report, May 15, 2020)
Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis
(Full-text paper in JAMA Network Open, May 1, 2020)
2020 Q1 Synthetic Cannabinoids Report (DEA, April 5, 2020)
Stigma and the Toll of Addiction (New England Journal of Medicine, April 2, 2020)
Trends in Alcohol-Induced Deaths in the United States, 2000-2016 (JAMA open network, March 24, 2020)
Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018
(CDC Report, March 20, 2020)
Complementary horse-assisted therapy for substance use disorders: a randomized controlled trial (Full-text article from Addiction Science and Clinical Practice, February 4, 2020)
Δ9-tetrahydrocannabinol exposure during rat pregnancy leads to symmetrical fetal growth restriction and labyrinth-specific vascular defects in the placenta (Full-text paper, Nature, January 19, 2020)
Trends in Total Binge Drinks per Adult Who Reported Binge Drinking — United States, 2011–2017 (CDC Report, January 17, 2020)
The Prevalence of Methamphetamine Use is Increasing Among Individuals Entering Medication-Assisted Treatment Programs for Opioid Use Disorders (January 8, 2020)
Marijuana: Legalization (National Council of State Legislatures, December 27, 2019)
Driving Under the Influence of Marijuana and Illicit Drugs Among Persons Aged ≥16 Years — United States, 2018 (CDC report, December 19, 2019)
Trends in Reported Marijuana Vaping Among US Adolescents, 2017-2019 (JAMA full-text letter, December 19, 2019)
A comprehensive study to delineate the role of an extracellular vesicle-associated microRNA-29a in chronic methamphetamine use disorder
Copyright © 2009-2020 JRW Behavioral Services. All rights reserved.